Corvus Pharmaceuticals
IPOPioneering ITK inhibition
Public · Burlingame, United States · Founded 2014 · $319.1M raised
- Headquarters
- Burlingame, California
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- corvuspharma.com
- Total Funding
- $319.1M
- Last Round
- $150.0M Corporate RoundJan 2026
- Rounds
- 5
- Type
- Public
About
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies with the potential to significantly improve the treatment of immune diseases and cancer. The company's lead program, soquelitinib, is a first-in-class oral therapy that selectively inhibits ITK (interleukin-2-inducible T-cell kinase) to modulate and control parallel signaling pathways in the immune system. The founding team includes inventors and scientists behind Rituxan (rituximab), Imbruvica (ibrutinib), and Zelboraf (vemurafenib). ITK inhibition represents a novel approach to immune modulation that the company believes parallels the transformative impact of those landmark therapies in oncology and autoimmune disease.
Summary
Corvus Pharmaceuticals is a Biotech company based in Burlingame, United States, founded in 2014. It has raised $319.1M in total across 5 rounds, most recently a $150.0M Corporate Round round in Jan 2026. Investors include OrbiMed, Rock Springs Capital and Adams Street Partners.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2026
Sign up to see all 6 rounds
Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/corvus-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/corvus-pharmaceuticals" alt="Corvus Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>